TOPRA news

Help shape our strategy for 2025-2030

Posted on 23/05/2024
As the leading membership body for healthcare regulatory affairs, our ambition is that TOPRA continues to be vibrant and relevant for our international community.

TOPRA is supporting the Global Pharma Regulatory Summit 2024

Posted on 22/05/2024
TOPRA has been confirmed as a supporter of the 13th Annual Global Pharma Regulatory Summit being held by Informa.

Sign up to Regulatory Rapporteur and get more

Posted on 17/05/2024
Regulatory Rapporteur is TOPRA’s respected online journal, published 11 times per year and available free to TOPRA members.

Recognising the contribution of TOPRA community volunteers

Posted on 13/03/2024
TOPRA’s volunteers play a vital role in enabling us to support our dynamic international community of members.

TOPRA is Association Partner at GCC Pharma Summit 2024

Posted on 11/03/2024
TOPRA has been confirmed as an Association Partner for the ninth GCC Regulatory Affairs Pharma Summit.

TOPRA rated ‘Good’ education provider by Ofsted

Posted on 02/02/2024
Ofsted has judged TOPRA as ‘Good’ in all areas in its recent full inspection of the training programme for the Level 7 Regulatory Affairs Specialist Apprenticeship.

TOPRA partners with EUPATI

Posted on 26/01/2024
TOPRA partners with EUPATI to support patient involvement in healthcare regulatory affairs.

No content found

No content found

No content found

No content found

No content found

No content found

No content found

No content found


Recently added consultations:

Human medicines
  • EMA: Guideline on registry-based studies
  • EMA: Guideline on SmPC for human normal immunoglobulin for intravenousadministration (IVIg)
  • EMA: Guideline on the clinical investigation of human normal immunoglobulin for intravenous administration (IVIg) 

Visit our Consultations page for more about these and other active consultations.